Literature DB >> 11097171

Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex.

M Orlowski1, S Wilk.   

Abstract

The proteasome, a multisubunit, multicatalytic proteinase complex, is attracting growing attention as the main intracellular, extralysosomal, proteolytic system involved in ubiquitin-(Ub) dependent and Ub-independent intracellular proteolysis. Its involvement in the mitotic cycle, and control of the half-life of most cellular proteins, functions absolutely necessary for cell growth and viability, make it an attractive target for researchers of intracellular metabolism and an important target for pharmacological intervention. The proteasome belongs to a new mechanistic class of proteases, the N-terminal nucleophile hydrolases, where the N-terminal threonine residue functions as the nucleophile. This minireview focuses on the three classical catalytic activities of the proteasome, designated chymotrypsin-like, trypsin-like, and peptidyl-glutamyl-peptide hydrolyzing in eukaryotes and also the activities of the more simple Archaebacteria and Eubacteria proteasomes. Other catalytic activities of the proteasome and their possible origin are also examined. The specificity of the catalytic components toward synthetic substrates, natural peptides, and proteins and their relationship to the catalytic centers are reviewed. Some unanswered questions and future research directions are suggested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097171     DOI: 10.1006/abbi.2000.2036

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  77 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

Authors:  Martina Bazzaro; Ravi K Anchoori; Mohana Krishna R Mudiam; Olga Issaenko; Srinivas Kumar; Balasubramanyam Karanam; Zhenhua Lin; Rachel Isaksson Vogel; Riccardo Gavioli; Federica Destro; Valeria Ferretti; Richard B S Roden; Saeed R Khan
Journal:  J Med Chem       Date:  2010-12-27       Impact factor: 7.446

3.  Proteolysis is depressed during torpor in hibernators at the level of the 20S core protease.

Authors:  Vanja Velickovska; Bryan P Lloyd; Safdar Qureshi; Frank van Breukelen
Journal:  J Comp Physiol B       Date:  2005-05-24       Impact factor: 2.200

4.  Posttranslational modification of the 20S proteasomal proteins of the archaeon Haloferax volcanii.

Authors:  Matthew A Humbard; Stanley M Stevens; Julie A Maupin-Furlow
Journal:  J Bacteriol       Date:  2006-09-01       Impact factor: 3.490

Review 5.  Aging and regulated protein degradation: who has the UPPer hand?

Authors:  Vita A Vernace; Thomas Schmidt-Glenewinkel; Maria E Figueiredo-Pereira
Journal:  Aging Cell       Date:  2007-08-06       Impact factor: 9.304

Review 6.  The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.

Authors:  Daniel E Johnson
Journal:  Endocr Relat Cancer       Date:  2014-03-21       Impact factor: 5.678

Review 7.  New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer.

Authors:  Di Chen; Q Ping Dou
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

Review 8.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

9.  A Sensitive High-Throughput Screening Method for Identifying Small Molecule Stimulators of the Core Particle of the Proteasome.

Authors:  Rachel A Coleman; Darci J Trader
Journal:  Curr Protoc Chem Biol       Date:  2018-10-04

10.  Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells.

Authors:  Claudia P Miller; Sharmistha Rudra; Michael J Keating; William G Wierda; Michael Palladino; Joya Chandra
Journal:  Blood       Date:  2009-01-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.